tirzepatide parkinson retatrutide parkinson's clinical trial Dual GLP-1 and GIP Agonist Exerted Neuroprotective Action in a Disease Rat Model retatrutide parkinson's disease clinical trial – tirzepatide and parkinson's disease Neuroprotection

10.1080/13543784.2023.228807338006580 8 Mitchell JL, Lyons HS, Walker JK, et al

Not everyone needs the maximal efficacy of a triple agonist

Exploring the clinical utility of angioinvasion markers in papillary thyroid cancer: a literature review

Things that feel warm or cool and kind of slide down easy

Phase II randomized trial of rituximab plus cyclophosphamide followed by belimumab for the treatment of lupus nephritis

Doctors are saying, Okay, well, take your GLP-1s and this is going to make you less motivated for food, but we somehow expect you to have more motivation to change your diet and to exercise. If its gonna dampen your desire to kind of eat, isnt it also going to dampen your desire, like that high you get from working out, or that [thought], Hey, I wanna be healthier, maybe I should go for a salad. If you think the only reason to eat better is to lose weight and something else is making you lose weight, that might actually give you inherently less motivation to eat better.